Bu sayfanın çevirisi deneyseldir ve geliştirilme aşamasındadır. imlerinizi bekliyoruz!
Ganfeng Lithium Group Geçmiş Kazanç Performansı
Geçmiş kriter kontrolleri 0/6
Ganfeng Lithium Group has been growing earnings at an average annual rate of 38.1%, while the Chemicals industry saw earnings growing at 6.3% annually. Revenues have been growing at an average rate of 43% per year.
Anahtar bilgiler
38.1%
Kazanç büyüme oranı
37.4%
EPS büyüme oranı
| Chemicals Sektör Büyümesi | 12.1% |
| Gelir büyüme oranı | 43.0% |
| Özkaynak getirisi | -4.4% |
| Net Marj | -6.8% |
| Sonraki Kazanç Güncellemesi | 31 Oct 2024 |
Yakın geçmiş performans güncellemeleri
Recent updates
Subdued Growth No Barrier To Ganfeng Lithium Group Co., Ltd. (SZSE:002460) With Shares Advancing 26%
Sep 30
We Think Ganfeng Lithium Group (SZSE:002460) Has A Fair Chunk Of Debt
Aug 18Ganfeng Lithium Group (SZSE:002460) Is Paying Out Less In Dividends Than Last Year
Jul 22Potential Upside For Ganfeng Lithium Group Co., Ltd. (SZSE:002460) Not Without Risk
Jun 03Investors Could Be Concerned With Ganfeng Lithium Group's (SZSE:002460) Returns On Capital
Apr 22Shaky Earnings May Not Tell The Whole Story For Ganfeng Lithium Group (SZSE:002460)
Apr 04Downgrade: Here's How Analysts See Ganfeng Lithium Group Co., Ltd. (SZSE:002460) Performing In The Near Term
Apr 02Earnings Miss: Ganfeng Lithium Group Co., Ltd. Missed EPS By 26% And Analysts Are Revising Their Forecasts
Apr 01Gelir ve Gider Dağılımı
Ganfeng Lithium Group nasıl para kazanır ve harcar. LTM bazında en son bildirilen kazançlara dayanmaktadır.
Kazanç ve Gelir Geçmişi
| Tarih | Gelir | Kazançlar | G+A Giderleri | Ar-Ge Giderleri |
|---|---|---|---|---|
| 30 Jun 24 | 24,415 | -1,664 | 1,413 | 1,065 |
| 31 Mar 24 | 28,591 | 2,111 | 1,366 | 1,076 |
| 31 Dec 23 | 32,972 | 4,947 | 1,230 | 1,251 |
| 30 Sep 23 | 39,893 | 11,719 | 1,326 | 997 |
| 30 Jun 23 | 45,524 | 19,100 | 1,169 | 1,120 |
| 31 Mar 23 | 45,895 | 19,375 | 1,078 | 1,188 |
| 01 Jan 23 | 41,823 | 20,504 | 1,107 | 1,007 |
| 30 Sep 22 | 31,720 | 17,550 | 793 | 1,090 |
| 30 Jun 22 | 21,542 | 11,065 | 792 | 779 |
| 31 Mar 22 | 14,921 | 8,277 | 712 | 514 |
| 01 Jan 22 | 11,162 | 5,228 | 526 | 339 |
| 30 Sep 21 | 8,685 | 3,167 | 334 | 263 |
| 30 Jun 21 | 7,201 | 2,285 | 294 | 185 |
| 31 Mar 21 | 6,052 | 1,493 | 253 | 155 |
| 31 Dec 20 | 5,524 | 1,025 | 250 | 140 |
| 30 Sep 20 | 5,024 | 359 | 293 | 103 |
| 30 Jun 20 | 4,906 | 219 | 197 | 90 |
| 31 Mar 20 | 5,091 | 113 | 333 | 83 |
| 31 Dec 19 | 5,342 | 358 | 351 | 80 |
| 30 Sep 19 | 5,621 | 698 | 452 | 74 |
| 30 Jun 19 | 5,494 | 912 | 438 | 72 |
| 31 Mar 19 | 5,284 | 1,356 | 339 | 68 |
| 31 Dec 18 | 5,004 | 1,341 | 368 | 63 |
| 30 Sep 18 | 5,135 | 1,438 | 327 | 54 |
| 30 Jun 18 | 5,090 | 1,587 | 302 | 65 |
| 31 Mar 18 | 4,808 | 1,571 | 265 | 51 |
| 31 Dec 17 | 4,383 | 1,469 | 210 | 38 |
| 30 Sep 17 | 3,664 | 982 | 159 | 27 |
| 30 Jun 17 | 3,126 | 794 | 182 | 0 |
| 31 Mar 17 | 2,806 | 493 | 170 | 0 |
| 31 Dec 16 | 2,844 | 464 | 161 | 0 |
| 30 Sep 16 | 2,509 | 526 | 140 | 0 |
| 30 Jun 16 | 2,153 | 352 | 127 | 0 |
| 31 Mar 16 | 1,788 | 208 | 118 | 0 |
| 31 Dec 15 | 1,354 | 125 | 109 | 0 |
| 30 Sep 15 | 1,107 | 111 | 96 | 0 |
| 30 Jun 15 | 1,007 | 98 | 89 | 0 |
| 31 Mar 15 | 921 | 90 | 86 | 0 |
| 31 Dec 14 | 869 | 86 | 84 | 0 |
| 30 Sep 14 | 819 | 80 | 78 | 0 |
| 30 Jun 14 | 764 | 78 | 73 | 0 |
| 31 Mar 14 | 707 | 76 | 69 | 0 |
| 31 Dec 13 | 686 | 74 | 68 | 0 |
Kaliteli Kazançlar: 002460 is currently unprofitable.
Büyüyen Kar Marjı: 002460 is currently unprofitable.
Serbest Nakit Akışı ve Kazanç Analizi
Geçmiş Kazanç Büyüme Analizi
Kazanç Eğilimi: 002460 is unprofitable, but has reduced losses over the past 5 years at a rate of 38.1% per year.
Büyüme Hızlandırma: Unable to compare 002460's earnings growth over the past year to its 5-year average as it is currently unprofitable
Kazançlar vs. Sektör: 002460 is unprofitable, making it difficult to compare its past year earnings growth to the Chemicals industry (-4.7%).
Özkaynak Getirisi
Yüksek ROE: 002460 has a negative Return on Equity (-4.44%), as it is currently unprofitable.